XOMA Royalty to Present at Investor Conferences in March

EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following investor conferences in March.  Management will also participate in one-on-one investor meetings.

T.D. Cowen 46th Annual Health Care Conference (March 2-4, 2026)

Format:

Fireside chat

Date: Monday, March 2, 2026

Time: 11:50AM ET

Location:

Boston, MA

Link: https://bit.ly/3JXiyRJ

Leerink 2026 Global Healthcare Conference (March 8-11, 2026)

Format: Fireside chat

Date: Wednesday, March 11, 2026

Time: 11:20AM ET

Location:

Miami Beach, FL

Link: https://bit.ly/499Y0Og

XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com.  A replay of each presentation will be available and archived on the site for 90 days after the event.

About XOMA Royalty Corporation XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.  XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.  When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes.  The Company has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate).  For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.

XOMA Investor Contact XOMA Media Contact

Juliane Snowden Kathy Vincent

XOMA Royalty  KV Consulting & Management

+1 646-438-9754 [email protected]

juliane.snowden@xoma.com

Source: XOMA Royalty Corporation